🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Love this team!!! Neuro-Oncology Sylvester Comprehensive Cancer Center UMiami Neurology

Happy #InternationalWomensDay2024 from the Neuro-oncology Division Sylvester Comprehensive Cancer Center UMiami Neurology

Looking forward to this talk. Dr. Tim Cloughesy on “Emerging Role of IDH inhibitors in IDH mutant Glioma”. Sylvester Comprehensive Cancer Center UMiami Neurology

Thanks so much for your support Dr. Estela Rodriguez! Sylvester Comprehensive Cancer Center UMiami Neurology

March is #NationalSocialWorkMonth 💪🏽and today I want to acknowledge Sylvester Comprehensive Cancer Center social workers like Lisset Robertson who are the true champions of #healthequity -without them we couldn’t address social determinants of health (SDOH) #socialworkersrock

📣Last day to apply for the SNO and Oxford University Press Editorial Scholar’s Program. This opportunity is offered to early career members to enhance their skills as reviewers of manuscripts for the Society’s journals. For more information and to apply: bit.ly/EdScholars

Excited to say that we are enrolling recurrent high-grade gliomas for a novel biomarker driven retroviral gene therapy trial! If you have any patients you would like to screen, please let us know! NCT06264388 Macarena de la Fuente Sylvester Comprehensive Cancer Center UM Neurosurgery National Cancer Institute

After a decade of work at Sylvester Comprehensive Cancer Center, I am so proud and excited to join forces with so many physicians, scientists and collaborators to accelerate discoveries and translate them to the clinic to benefit brain tumor patients. UMiami Neurology SNO

Join us at #ASCO24 to hear all about IDHm glioma therapies! Sylvester Comprehensive Cancer Center UMiami Neurology @DrFlorienBoele

Thanks Sylvester Comprehensive Cancer Center for the commitment and support. We aim for more effective and less toxic treatments for brain tumor patients. UMiami Neurology UMiami Health System

Join us tomorrow ASCO #ASCO24 #btsm All what you need to know about IDHm gliomas with Drs. Wen, Preusser and @DrFlorienBoele Sylvester Comprehensive Cancer Center SNO

GBM AGILE leadership gathering at #ASCO24 Trial leadership joined together to plan new trial innovations, advance exciting new therapies, and celebrate five years of our commitment to patients by making clinical research more efficient. Since launching in 2019, six

Dr. John de Groot, MD, Chief of Neuro-Oncology at UC San Francisco, Arm Co-PI of VAL-083 and GBM AGILE Arm Selection Committee Member presented results of the VAL-083 experimental arm of #GBMAGILE at #ASCO24 Key takeaways- - GBM AGILE is a global adaptive platform trial designed to rapidly

📌 Incorporating Targeted Therapy Into Neuro-Oncology Practice ascopubs.org/doi/10.1200/ED… 👉🏻 This review presents a comprehensive framework for optimizing drug selection in neuro-oncology from IDH-mutant gliomas to rarer FGFR/NTRK-driven tumors and highlights the key role of tumor

Sharing this new trial led by Ashish H. Shah Very innovative approach for patients with ND unresectable GBM who often are not eligible for clinical trials. Now enrolling at Sylvester Comprehensive Cancer Center UMiami Neurology

🧠 Ready to advance your LGG care strategy? Gain expert insights on selecting the right patients for targeted therapy & how to apply it across your clinical team. 🌟 Don’t miss this! Register now: ms.spr.ly/6010q7L8C 👥 Michael Lim, MD, Macarena de la Fuente, and Mitchel S. Berger,

Join us tomorrow to talk about IDHm glioma. Medscape Oncology Sylvester Comprehensive Cancer Center UMiami Neurology

TODAY is our Head to the Hill Day of Action! Take 2 minutes to sign our action alert — it urges your members of Congress to ✅ Fund more #braintumor research ✅ Support patient-first policies Let’s raise our voices together: 👉 p2a.co/Z9dMpdQ #Head2Hill

On #GBM awareness day, We are incredibly grateful to receive critical support from StacheStrong Sylvester Comprehensive Cancer Center for our work on GBM. Funding from foundations and donors drive our research and allows us to keep pushing forward. Thank you. #wewontstop UM SVI LAB

Proud to announce that we are now enrolling patients for a Phase 1/2 surgical study for upfront GBM using intratumoral and IV retroviral gene therapy along with SOC. Sylvester Comprehensive Cancer Center will be the only site outside of California offering this trial. Macarena de la Fuente